Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 353,127 | 406,239 | 275,339 | 247,055 | 207,887 |
| Marketable Securities | 383,482 | 406,141 | 363,205 | 424,196 | 386,660 |
| Receivables | 222,764 | 236,364 | 279,064 | 256,731 | 199,018 |
| Inventories | 216,865 | 222,107 | 219,787 | 208,894 | 198,566 |
| Other current assets | 84,778 | 73,939 | 65,441 | 65,525 | 80,231 |
| TOTAL | $1,261,016 | $1,344,790 | $1,202,836 | $1,202,401 | $1,072,362 |
| Non-Current Assets | |||||
| PPE Net | 782,774 | 791,540 | 789,788 | 788,652 | 784,707 |
| Investments And Advances | 53,450 | 55,720 | 67,480 | 68,640 | 71,570 |
| Other Non-Current Assets | 353,010 | 355,440 | 343,820 | 342,770 | 324,070 |
| TOTAL | $1,189,234 | $1,202,700 | $1,201,088 | $1,200,062 | $1,180,347 |
| Total Assets | $1,873,273 | $1,965,559 | $1,827,031 | $1,832,397 | $1,688,244 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,740 | 44,230 | 101,550 | 82,000 | 76,260 |
| Accrued Expenses | 99,690 | 93,970 | 73,210 | 93,230 | 81,640 |
| Other current liabilities | 90,760 | 91,710 | 83,290 | 100,130 | 73,600 |
| TOTAL | $251,632 | $240,448 | $266,451 | $291,011 | $251,907 |
| Non-Current Liabilities | |||||
| Long Term Debt | 108,235 | 114,766 | 112,798 | 105,592 | 106,773 |
| Other Non-Current Liabilities | 373,410 | 379,180 | 110,070 | 107,650 | 94,500 |
| TOTAL | $651,455 | $660,456 | $222,868 | $213,242 | $201,273 |
| Total Liabilities | $903,092 | $900,914 | $489,323 | $504,259 | $453,189 |
| Shareholders' Equity | |||||
| Common Shares | 1,195,230 | 1,279,730 | 1,251,240 | 1,206,880 | 1,132,760 |
| Retained earnings | -224,583 | -217,076 | 87,631 | 124,132 | 107,390 |
| Other shareholders' equity | -466 | 1,991 | -1,163 | -2,874 | -5,095 |
| TOTAL | $970,181 | $1,064,645 | $1,337,708 | $1,328,138 | $1,235,055 |
| Total Liabilities And Equity | $1,873,273 | $1,965,559 | $1,827,031 | $1,832,397 | $1,688,244 |